Stay updated with breaking news from Thyrocare Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vijaya Diagnostic IPO: The public offerwill be an offer for sale of 35,688,064 equity shares by promoters, i.e. Dr S Surendranath Reddy and investors Karakoram, and Kedaara Capital Alternative Investment Fund
: Monday, May 17, 2021, 12:47 AM IST Stocks to watch today: L&T, SKF India, Camlin Fine Sciences, Cipla, Aditya Birla Capital, Bata India, Escorts, Thyrocare, Shriram City Union, Hero MotoCorp among others Stocks to watch today: L&T, SKF India, Camlin Fine Sciences, Cipla, Aditya Birla Capital, Bata India, Escorts, Thyrocare, Shriram City Union, Hero MotoCorp among others Some companies happened to perform well despite COVID-19 and subsequent lockdown. So, those companies can be of investors' interest. Here is the list of stocks for Monday: Camlin Fine Sciences: Mumbai-based Camlin Fine Scie...
Express News Service BENGALURU: Despite repeated warnings from members of the Covid Technical Advisory Committee (TAC) not to reduce testing, the Department of Health and Family Welfare has consistently reduced the number of tests over the last three weeks. As per the health bulletin data, testing has fallen from 1.46 lakh RTPCR tests on May 8 to 1.04 lakh tests on Tuesday.“It is not a good trend. In the last two days, testing has come down but the positivity rate remains high. This shows that the virus is spreading faster,” said Dr C N Manjunath, nodal officer for Covid testing and h...
ICICI Securities has reduce call on Thyrocare Technologies with a target price of Rs 985. The current market price of Thyrocare Technologies Ltd. is Rs 1043.25. Thyrocare Technologies Ltd., incorporated in the year 2000, is a Mid Cap company (having a market cap of Rs 5627.95 Crore) operating in Hospitals & Allied Services sector. Financials For the quarter ended 31-03-2021, the company reported a Consolidated Total Income of Rs 150.48 Crore, up 6.84 % from last quarter Total Income of Rs 140.85 Crore and up 45.39 % from last year same quarter Total Income of Rs 103.50 Crore. Company repor...
Thyrocare Technologies rose 1.46% to Rs 1074.45 after the company reported a consolidated net profit of Rs 37.75 crore in Q4 FY21 compared with net loss of Rs 1.60 crore in Q4 FY20. Net sales during the quarter increased 44.8% year-on-year (YoY) to Rs 146.84 crore. On the segmental front, revenue from diagnostic testing services was at Rs 138.68 crore (up 49.4% YoY), revenue from imaging services was at Rs 7.68 crore (down 5.2% YoY) in the fourth quarter. Profit before tax stood at Rs 47.63 crore in Q4 FY21, up 171.2% from Rs 17.56 crore in Q4 FY20. Current tax outgo jumped by 48% to Rs 14.3...